What volume of sterile diluent should be added to reconstitute a tobramycin vial to obtain a 10 mg/mL solution, and how should it be further diluted for intramuscular injection or intravenous infusion?

Tobramycin Reconstitution and Dilution for Intravenous Administration

For intravenous administration, reconstitute the 1.2 g tobramycin pharmacy bulk vial with 30 mL of Sterile Water for Injection to achieve a 40 mg/mL solution, then further dilute the required dose in 50-100 mL of 0.9% Sodium Chloride or 5% Dextrose for adults (proportionately less for pediatric patients) and infuse over 20-60 minutes. 1

Reconstitution Process

Step 1: Initial Reconstitution

• Add 30 mL of Sterile Water for Injection, USP to the 1.2 g tobramycin pharmacy bulk vial 1
• This produces a 40 mg/mL concentration 1
• Use aseptic technique throughout the preparation 1

Step 2: Further Dilution for IV Infusion

• Withdraw the calculated dose volume from the reconstituted 40 mg/mL solution 1
• Add this to 50-100 mL of diluent for adult doses (either 0.9% Sodium Chloride Injection or 5% Dextrose Injection) 1
• For pediatric patients, use proportionately less diluent than for adults 1

Administration Guidelines

Infusion Rate

• Infuse the diluted solution over 20-60 minutes 1
• Do not infuse in less than 20 minutes as peak serum concentrations may exceed 12 mcg/mL, increasing toxicity risk 1

Timing Constraints

• After penetrating the pharmacy bulk vial, dispense entire contents within 24 hours 1
• Visually inspect for particulate matter and discoloration before administration 1

Important Safety Considerations

Peak Concentration Management

• The 20-60 minute infusion window is critical to avoid peak concentrations above 12 mcg/mL, which are associated with increased nephrotoxicity and ototoxicity 1
• Rapid IV administration (less than 20 minutes) can produce transient peaks exceeding 20 mcg/mL in some patients 2

Drug Incompatibility

• Never physically premix tobramycin with other drugs 1
• Administer separately according to recommended dose and route 1

Monitoring Requirements

• Measure peak serum concentrations approximately 30 minutes after completing the IV infusion 1
• Target peak concentrations of 4-6 mcg/mL for adequate therapy 2
• Avoid peak concentrations above 12 mcg/mL 1
• Monitor trough concentrations (drawn just before next dose) and keep below 2 mcg/mL to prevent accumulation 1